Private equity investing in the healthcare sector in 2022 can be characterized by the lagging effects from COVID-19 and the current effect of financial markets.
Market data, powered by Pitchbook, shows a five-year trend of more deals propelled by underlying demographics, regulatory and market drivers. A potential anomaly was the sharp spike in deal volume in 2021, which is partly attributed to the postponement of certain deals from 2020 due to COVID-19 rather than underlying conditions.
Deal activity within the healthcare sector in 2022 has remained strong and it is likely that underlying market conditions will continue to drive growth with a focus on consolidation and build out of platform deals that traded in 2021 and early 2022, despite some developing headwinds.
Our private equity featured industry insights
No Results Found. Please search again using different keywords and/or filters.